Search clinical trials for: Endobronchial Valve (EBV) Procedure

Total 9465 results

The University of Hong Kong

Unknown

Weekly Plasma EBV DNA for Non-metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Hong Kong
Cell Medica Ltd

Terminated

Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma (CITADEL)

Lymphoma, Extranodal NK-T-Cell | EBV

Korea, Republic of, United States, France, United Kingdom
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

124I-FIAU Imaging in EBV and KSHV Associated Cancers

Nasopharyngeal Cancer | Gastric Cancer | Hodgkin Lymphoma | Non Hodgkin Lymphoma | Kaposi's Sarcoma

United States
Beijing Friendship Hospital

Unknown

L-DEP as an Initial Treatment for EBV-HLH

Hemophagocytic Lymphohistiocytosis

China
Huiqiang Huang

Unknown

Differences Between Chidamide Taken Daily and Twice a Week in Therapeutic Effect，Pharmacokinetics, Pharmacodynamics and EB Virus Activation

Lymphoma, Extranodal NK-T-Cell | EBV
Catherine Bollard

Active, not recruiting

Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma (ALCI2)

Hodgkin Disease | Non Hodgkin Lymphoma | Leiomyosarcoma | Lymphoepithelioma | Severe Chronic Active EBV Infection Syndrome (SCAEBV)

United States
Baylor College of Medicine
The Methodist Hospital Research Institute; Center for Cell and Gene Therapy...

Terminated

LMP2a-Specific Cytotoxic T-Lymphocytes, Lymphoma (ACDAL) (ACDAL)

Lymphoma

United States
Beijing Friendship Hospital

Unknown

Etoposide in the First-line Treatment of Adult EBV-HLH

Hemophagocytic Lymphohistiocytosis

China
Baylor College of Medicine
M.D. Anderson Cancer Center; The Methodist Hospital Research Institute; Center...

Completed

Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes (CADEN)

Nasopharyngeal Carcinoma

United States
Centre Hospitalier Universitaire, Amiens

Completed

Comparison of Technics for Determination of Epstein-Barr Virus Serological Diagnosis (DIAGEPS)

EBV
Baylor College of Medicine
National Cancer Institute (NCI); The Methodist Hospital Research Institute; Center...

Active, not recruiting

TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC

EBV-positive Nasopharyngeal Carcinoma

United States
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections

Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | MDS (Myelodysplastic Syndrome) | CML (Chronic Myelogenous Leukemia) | AML (Acute Myelogenous Leukemia)

United States
Memorial Sloan Kettering Cancer Center

Completed

Rituximab (Rituxan) for the Prevention of EBV-LPD Epstein Barr Virus (EBV) Lymphoproliferative Disorder Post T Cell Depleted Unrelated and HLA Mis-matched Related HSCT

Leukemia | Non-Hodgkin's Lymphoma | Myelodysplastic Syndrome | Hodgkin's Disease

United States
Centre Hospitalier Universitaire de Nice

Unknown

Chronic Presence of Epstein Barr Virus in Epithelial Cells From Gingiva is Associated With Periodontitis

Aggressive Periodontitis | Chronic Periodontitis | Presence / Absence of EBV

France
Sun Yat-sen University
Wuzhou Red Cross Hospital; First People's Hospital of Foshan; National Cancer...

Active, not recruiting

EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR) (EP-STAR)

Nasopharyngeal Carcinoma

China
Hanoi Medical University
Karolinska Institutet; Swedish International Development Cooperation Agency...

Completed

A Controlled Clinical Trial on The Use of a Specific Antivenom Against Envenoming by Bungarus Multicinctus

Snake Bite

Vietnam
Labo'Life

Recruiting

Study to Evaluate the Efficacy of 2LEBV® and 2LXFS® on Asthenia in Patients With an Epstein-Barr Virus Infection (EBVAST)

EBV Infection

Belgium
Children's Hospital Medical Center, Cincinnati

Recruiting

Third Party Viral Specific T-cells (VSTs)

Viral Infection | Viral Reactivation | Infection in an Immunocompromised Host

United States
Beijing Friendship Hospital

Recruiting

PD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBV

EBV Infection

China
University Health Network, Toronto

Completed

Positron Emission Tomography Scanning and Epstein-Barr Virus DNA Levels in the Staging and Follow-up of Nasopharyngeal Carcinoma.

Nasopharyngeal Carcinoma

Canada
Cullinan Oncology, LLC
National Cancer Institute (NCI)

Terminated

Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC)

Nasopharyngeal Carcinoma | Nasopharyngeal Cancer

France, Singapore, United States, China, Hong Kong
Beijing Friendship Hospital

Unknown

L-DEP Regimen as a Salvage Therapy for Refractory Epstein Barr Virus-induced Hemophagocytic Lymphohistiocytosis

Hemophagocytic Lymphohistiocytosis

China
National Cancer Centre, Singapore

Recruiting

Treatment Individualisation by EBV Stratification in Nasopharyngeal Carcinoma: a Prospective Observational Study

Nasopharyngeal Carcinoma

Singapore
Eutilex

Recruiting

A Multi-center, Single-arm, Open, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of EBViNT Cell (EBV Specific Autologous CD8+ T Cell) in Patients With Treatment Failed Epstein Barr Virus (EBV)-Positive Malignancies

EBV Associated Extranodal NK/T-cell Lymphoma | EBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma

Korea, Republic of
University Hospital, Strasbourg, France

Recruiting

Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Received an EBV Seropositive Kidney Allograft (REPLY)

Epstein-Barr Virus Infections

France
Centre Hospitalier Universitaire de Nice

Recruiting

Epstein Barr Virus Infection in Patients With Radiologically Isolated Syndrome (EBV-RIS)

Multiple Sclerosis | Radiologically Isolated Syndrome | Epstein-Barr Virus

France
Beijing Friendship Hospital

Recruiting

DEP Combine With PD-1 Antibody as an Treatment for EBV-HLH

Hemophagocytic Lymphohistiocytosis

China
Baylor College of Medicine
Duke University; University of Texas Southwestern Medical Center; Children's... and other collaborators

No longer available

Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH) (EAP CHALLAH)

Adenoviral Infection | CMV Infection | EBV Infection

United States
Atara Biotherapeutics
Merck Sharp & Dohme LLC

Terminated

Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)

Nasopharyngeal Carcinoma | Nasopharyngeal Neoplasms | Epstein-Barr Virus Infections | Epstein-Barr Viraemia | Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)

United States
Baylor College of Medicine
The Methodist Hospital Research Institute

Terminated

Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma (ALDI)

Non-Hodgkin Lymphoma | Hodgkins Lymphoma

United States
Beijing Friendship Hospital

Not yet recruiting

Segmental Resection Combined With DEP Regimen for EBV-HLH Patients With Intestinal Involvement

Hemophagocytic Lymphohistiocytosis | Bowel Resection | Epstein-Barr Virus

China
Stanford University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Recruiting

Clinical Trial of a Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies

Nasopharyngeal Cancer | Epstein-Barr Virus Related Carcinoma

United States
Ruijin Hospital

Recruiting

Zanubrutinib Combined With Tislelizumab in the Treatment of r/r PMBCL and EBV+ DLBCL

Primary Mediastinal Large B Cell Lymphoma | EBV-Positive DLBCL, Nos

China
Chinese University of Hong Kong
Hong Kong Nasopharyngeal Cancer Study Group Limited

Completed

A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy

Nasopharyngeal Cancer

Hong Kong
H. Lee Moffitt Cancer Center and Research Institute
Seagen Inc.

Withdrawn

Brentuximab Vedotin in CD30 Positive Epstein Barr Virus (EBV) Positive DLBCL of Elderly

Lymphoma
Celgene

Completed

Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

Canada, United States, Taiwan, France, Spain, Greece, Italy, Singapore, Tunisia
The Christie NHS Foundation Trust

Not yet recruiting

Exploratory Study of EBV DNA Titre Clearance Whilst on Proton Beam Therapy (ClearED)

Head and Neck Cancer | Nasopharyngeal Carcinoma | Nasopharyngeal Cancer | Epstein-Barr Virus
Baylor College of Medicine
The Methodist Hospital Research Institute; Center for Cell and Gene Therapy...

Completed

LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA) (NATELLA)

Nasopharyngeal Carcinoma

United States
University Hospital, Basel, Switzerland

Recruiting

A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System® (CCS)

Cytomegalovirus Infections | EBV | Adenovirus Infection | Cytokine Capture System | Allogenic Disease

Switzerland
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Terminated

Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia

Acute Myeloid Leukemia | EBV-Positive Neoplastic Cells Present | HLA-A*0201 Positive Cells Present | Blasts Under 5 Percent of Bone Marrow Nucleated Cells | Elevated WT1

United States
Fudan University

Recruiting

Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT

Nasopharyngeal Cancer

China
National Taiwan University Hospital

Unknown

Reproducibility and Reliability of Epstein-Barr Virus (EBV) DNA/RNA Measures in Nasopharyngeal Swabs

Suspect NPC Patients | NPC Multiplex Families

Taiwan
Peking University People's Hospital

Not yet recruiting

Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT

Stem Cell Transplant | CMV Infection | EBV Infection
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

A Retrospective Study Reveals the Relationship Between gp42-IgG Epitopes and EBV-associated NPC

Nasopharyngeal Carcinoma

China
Beijing Friendship Hospital

Recruiting

Thiotepa Incorporating TBI/Cy Conditioning Regimen for EBV-HLH With Central Nervous System Involvement

HLH

China
Sun Yat-sen University

Unknown

Chidamide for Patients With Recurrent and Metastatic Epstein-Barr Virus (EBV)-Associated Solid Tumors

Experimental Tumor

China
Northwestern University
Seagen Inc.

Terminated

Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Adult Immunoblastic Large Cell... and other conditions

United States
Johns Hopkins University
National University Hospital of Singapore

Withdrawn

Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Singapore
Baylor College of Medicine
The Methodist Hospital Research Institute; Center for Cell and Gene Therapy...

Completed

Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases (MALTED)

Nasopharyngeal Carcinoma | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | Leiomyosarcoma | Lymphoproliferative Disorder | Severe Chronic Active EBV (SCAEBV)

United States
Milton S. Hershey Medical Center

Unknown

Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma

Sarcoma | Neuroblastoma

United States

Search clinical trials for: Endobronchial Valve (EBV) Procedure

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations